Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration.

MLA

Tani, Hideki, et al. “Therapeutic Effects of Favipiravir against Severe Fever with Thrombocytopenia Syndrome Virus Infection in a Lethal Mouse Model: Dose-Efficacy Studies upon Oral Administration.” PLoS ONE, vol. 13, no. 10, Oct. 2018, pp. 1–10. EBSCOhost, https://doi.org/10.1371/journal.pone.0206416.

APA

Tani, H., Komeno, T., Fukuma, A., Fukushi, S., Taniguchi, S., Shimojima, M., Uda, A., Morikawa, S., Nakajima, N., Furuta, Y., & Saijo, M. (2018). Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration. PLoS ONE, 13(10), 1–10. https://doi.org/10.1371/journal.pone.0206416

Chicago

Tani, Hideki, Takashi Komeno, Aiko Fukuma, Shuetsu Fukushi, Satoshi Taniguchi, Masayuki Shimojima, Akihiko Uda, et al. 2018. “Therapeutic Effects of Favipiravir against Severe Fever with Thrombocytopenia Syndrome Virus Infection in a Lethal Mouse Model: Dose-Efficacy Studies upon Oral Administration.” PLoS ONE 13 (10): 1–10. doi:10.1371/journal.pone.0206416.